“A Letter to My 2020 Self”
Editor's Note: Patient Worthy is proud to share this blog post by Carmen D., a cancer survivor and affectionately known as The Chemo Diva. To see the article in its…
Continue Reading
“A Letter to My 2020 Self”
Worms Lead the Way in Rare Disease Drug Discovery
A groundbreaking study from the MRC London Institute of Medical Sciences (LMS) is reshaping how researchers approach treatment development for rare genetic disorders. Led by Dr. André Brown and the…
Continue Reading
Worms Lead the Way in Rare Disease Drug Discovery
A New Era for Chronic Spontaneous Urticaria: FDA Approves Rhapsido® (Remibrutinib), the First Oral BTK Inhibitor Treatment
On October 2, 2025, Novartis announced a significant milestone in the treatment of chronic spontaneous urticaria (CSU): the US Food and Drug Administration (FDA) approved Rhapsido® (remibrutinib) as the first…
Continue Reading
A New Era for Chronic Spontaneous Urticaria: FDA Approves Rhapsido® (Remibrutinib), the First Oral BTK Inhibitor Treatment
